New deadly mpox strain case confirmed in UK
- Health officials confirmed a fifth case of the new mpox strain in the UK.
- The latest patient from Leeds has no known connections to previous cases.
- Despite the new case, authorities consider the public threat level to be low.
In the United Kingdom, health officials confirmed the detection of a new case of an ultra-deadly strain of mpox, bringing the total confirmed cases in the country to five. The latest patient, who resides in Leeds, has no known links to the previous four cases that were identified earlier in London. Despite the increase in confirmed cases, health authorities maintain that the overall threat level to the public remains low. The unidentified patient is currently receiving specialized care at Sheffield Teaching Hospitals NHS Foundation Trust, which is 160 miles away from where the initial cases were reported. Health officials are unsure how the latest individual contracted the new strain. Testing of all contacts related to this fifth case will be conducted, and vaccination will be offered as necessary to those exposed. Recently, three patients were treated at Guy's and St Thomas' NHS Foundation Trust, all of whom were part of the same household and have since fully recovered. This indicates that while new cases are emerging, the existing ones have been successfully managed. The current global outbreak of mpox, formerly known as monkeypox, originated in Africa in May 2022 and has now reached several countries, with fatalities particularly high in the Democratic Republic of Congo, among others. The new clade 1b strain of mpox is considered significantly more virulent than earlier strains, prompting health experts to be vigilant. The World Health Organization declared the outbreak in central Africa as a public health emergency of international concern earlier this year. Preventative strategies are in place, which include recommending vaccinations within a specific time frame after potential exposure to the virus. Although the world has seen severe consequences from past pandemics, officials are hopeful that due to improved healthcare systems in developed nations like the UK, the fatality rates observed in central Africa may not be replicated.